Sildenafil in HFpEF (Heart Failure With Preserved Ejection Fraction) and PH
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Aim of the study is to investigate whether Sildenafil treatment results in a reduction of
pulmonary artery pressure without decrease of cardiac output (CO) and in improvement of
exercise capacity in patients with heart failure with preserved ejection fraction (HFpEF)
with pulmonary hypertension ( PH).